Metabolic phenotypes of retinoic acid and the risk of lung cancer.

The metabolic activity of cytochrome P-450 enzymes has been associated with an increased risk of developing lung cancer. We found previously that all-trans retinoic acid is catabolized by these oxidative enzymes, and that an inhibitor of this system discriminated between two populations of lung cancer patients. We examined the association between this metabolic phenotype and the risk of lung cancer in 85 subjects. The area under the plasma concentration x time curve (AUC) was calculated after a single oral dose of all-trans retinoic acid (45 mg/m2). The mean AUC for patients who had either squamous or large cell carcinomas was significantly lower than that of patients with adenocarcinomas (P = 0.0001) or control subjects (P = 0.01). Individuals with an AUC < 250 ng x h/ml had a greater likelihood of having squamous or large cell carcinoma (odds ratio = 5.93). This study suggests that the "rapid" catabolism of all-trans retinoic acid is linked to an increased risk of squamous or large cell cancers of the lung.

[1]  J S Lee,et al.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.

[2]  R. Hoover,et al.  Debrisoquine metabolism and lung cancer risk. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  A. Y. Lu,et al.  Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[4]  R C Brownson,et al.  Lung cancer in nonsmoking women. Histology and survival patterns , 1995, Cancer.

[5]  M. Pfahl,et al.  A specific defect in the retinoic acid response associated with human lung cancer cell lines. , 1994, Cancer research.

[6]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. , 1994, Cancer research.

[7]  C. Jara,et al.  Debrisoquin oxidation genotype and susceptibility to lung cancer , 1994, Clinical pharmacology and therapeutics.

[8]  M. Kris,et al.  Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. , 1993, Journal of the National Cancer Institute.

[9]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. P. Zhao,et al.  Intake of specific carotenoids and lung cancer risk. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  C. Young,et al.  Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms. , 1993, Cancer research.

[12]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R C Brownson,et al.  Gender and histologic type variations in smoking-related risk of lung cancer. , 1992, Epidemiology.

[14]  E. Fontham,et al.  Lung cancer in nonsmoking women: a multicenter case-control study. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  P. Chambon,et al.  Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. , 1991, Experimental cell research.

[16]  L. Pickle,et al.  Lung cancer and the debrisoquine metabolic phenotype. , 1990, Journal of the National Cancer Institute.

[17]  G. Mathé,et al.  DEGREE OF BRONCHIAL METAPLASIA IN HEAVY SMOKERS AND ITS REGRESSION AFTER TREATMENT WITH A RETINOID , 1982, The Lancet.

[18]  S. Wolbach,et al.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.